Clinical trial
The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
NCT06913699 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
- Lead sponsor
- Shanghai East Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 1, 2024
- Completion date
- May 31, 2026
- Enrollment
- 6 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-alcoholic fatty liver disease (nafld)